Elissa A Boguslawski

5PUBLICATIONS
36CO-AUTHORS
Molecular targetsBiologically active moleculesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 16, 2026
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.

|Feb 16, 2026
Mithramycin alters EWS::FLI1 DNA binding and RNA polymerase II processivity to inhibit nascent transcription.

Rebecca Kaufman, Guillermo Flores, Elissa A Boguslawski

|Mar 20, 2024
Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing Sarcoma.

Jennifer Jess, Katie M Sorensen, Elissa A Boguslawski

|Dec 22, 2022
Endometrial hyperplasia with loss of APC in a novel population of Lyz2-expressing mouse endometrial epithelial cells.

Susan M Kitchen-Goosen, Heather Schumacher, Julie Good

|Jun 03, 2022
Lurbinectedin Inhibits the EWS-WT1 Transcription Factor in Desmoplastic Small Round Cell Tumor.

Jenna M Gedminas, Rebecca Kaufman, Elissa A Boguslawski

Pageof 1

Frequent Collaborators

4 joint publications

Rebecca Kaufman

4 joint publications

Patrick J Grohar

2 joint publications

Jenna M Gedminas

2 joint publications

Marie Adams